___

• 1. Klockgether T. Ataxias. In Goetz C, Textbook of Clinical Neurology. 3rd ed, New York: Saunders, 2007; Chapter 35,765-780.
• 2. Saner N, Başak AN. Heterojen Bir Hastalık Grubu: Spinoserebellar ataksiler, Genetik Yapıları ve Moleküler Tanıları. Türk Nöroloji Dergisi 2006; 12: 185-194.
• 3. Bird TD. Hereditary Ataxia overview. Erişim. http://www.geneclinics.org
• 4. Gomez CM, Subramony SH. Dominantly Inherited Ataxias. Seminars in Pediatric Neurology 2003; 10: 210-222.
• 5. http://neuromuscular.wustl.edu/ ataxia 22 Ocak 2010 6. Bradley WG, Daraff RB, Fenichel GM, Jankoviz J. (Eds). Neurology in Clinical Practice . Chapter 75. 5th ed. Philadelphia: Butterworth-Heinemann 2008; 76: 2123-2145.
• 7. Gros-Louis F, Dupré N, Dion P, Fox MA, et al. Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat Genet 2007; 39: 80-85.
• 8. Dupre N, Gros-Louis F, Chrestian N, et al. A. Clinical and genetic study of autosomal recessive cerebellar ataxia type 1. Ann Neurol 2007;62:93-98.
• 9. Lagier-Tourenne C, Tazir M, Lopez LC, et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q(10) deficiency. Am J Hum Genet 2008; 82: 661-672.
• 10. Mollet J, Delahodde A, Serre V, et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 2008; 82: 623-630.
• 11. Gueven N, Becherel OJ, Kijas A, et al. Aprataxin, a novel protein that protects against genotoxic stress. Hum Molec Genet 2004; 13: 1081-1093.
• 12. Amouri R, Moreira MC, Zouari M, El Euch G, et al. Aprataxin gene mutations in Tunisian families Neurology 2004; 63: 928-929.
• 13. Moreira MC, Klur S, Watanabe M, et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nature Genet 2004; 36: 225-227.
• 14. Asaka T, Yokoji H, Ito J, et al. Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX. Neurology 2006; 66: 1580-1581.
• 15. Sanal O, Wei S, Foroud T, et al. Further mapping of an ataxia-telangiectasia locus to the chromosome 11q23 region. Am J Hum Genet 1990; 47: 860-866.
• 16. Renwick A, Thompson D, Seal S, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 2006; 38(8): 873-5.
• 17. Harding AE, Matthews S, Jones S, et al. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. New Eng J Med 1985; 313: 32-35.
• 18. Arita M, Sato Y, Miyata A. et al. Human alpha-tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem J 1995; 306: 437-443.
• 19. Ben Hamida C, Doerflinger N, Belal S, et al. Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nature Genet 1993; 5: 195-200.
• 20. Nystuen A, Benke P J, Merren J, et al. A cerebellar ataxia locus identified by DNA pooling to search for linkage disequilibrium in an isolated population from the Cayman Islands. Hum Molec Genet 1996; 5: 525-531.
• 21. Mrisca N, Belal S, Hamida CB, et al. Linkage to chromosome 13q11-12 of an autosomal recessive cerebellar ataxia in a Tunisian family. Neurology 2000; 54: 1408-1414.
• 22. El Euch-Fayache G, Lalani I, Amouri R, et al. Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia. Arch Neurol 2003; 60: 982-988.
• 23. Nikali K, Suomalainen A, Saharinen J, et al. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum Mol Genet 2005; 14: 2981-90.
• 24. Hakonen AH, Heiskanen S, Juvonen V, et al. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 2005; 77: 430-41.
• 25. Pasquier L, Laugel V, Lazaro L, et al. Wide clinical variability among 13 new Cockayne syndrome cases confirmed by biochemical aSCAys. Arch Dis Child 2006; 91, 178–182.
• 26. Funaki S, Takahashi S, Murakami H, et al. Cockayne syndrome with recurrent acute tubulointerstitial nephritis. Pathol Int 2006; 56: 678–682.
• 27. Reiss U, Hofweber K, Herterich R, et al. Nephrotic syndrome, hypertension, and adrenal failure in atypical Cockayne Syndrome. Pediatr Nephrol 1996; 10: 602–605.
• 28. Weidenheim KM, Dickson DW, Rapin I. Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration. Mechanisms of Ageing and Development 2009;130: 619–636.
• 29. Anna-Kaisa Anttonen, Eija Siintola, Lisbeth Tranebjaerg, et al. Novel SIL1 mutations and exclusion of functional candidate genes in Marinesco–Sjögren syndrome. European Journal of Human Genetics 2008; 16: 961–969.
• 30. JM Van Raamsdonk . Loss of function mutations in SIL1 cause Marinesco-Sjögren syndrome. Clin Genet 2006; 69: 399–403.
• 31. Ibrahim Mahjneh, Anna-Kaisa Anttonen, Mirja Somer, et al. Myopathy is a prominent feature in Marinesco-Sjögren syndrome, A muscle computed tomography study. J Neurol 2006; 253 : 301–306
• 32. Anne Slavotinek, Jill Goldman, Kara Weisiger, et al. Marinesco–Sjo¨gren Syndrome in a Male With Mild Dysmorphism. American Journal of Medical Genetics 2005; 133A: 197-201.
• 33. Reinker K, Hsia YE, Rimoin DL, et al. Orthopaedic Manifestations of Marinesco-Sjögren Syndrome. Journal of Pediatric Orthopaedics 2002;22:399–403.
• 34. Harting I, Blaschek A, Wolf NI, et al. T2-hyperintense cerebellar cortex in Marinesco–Sjögren syndrome. Neurology 2004; 63: 2448-2449.
• 35. Christodoulou K, Deymeer F Serdaroglu P, et al. Mapping of the second Friedreich's ataxia (FA2) locus to chromosome 9p23-p11: evidence for further locus heterogeneity. Neurogenetics 2001; 3: 127-132
• 36. Delatycki MB, Williamson R, Forrest SM. Friedreich ataxia: an overview. J Med Genet 2000; 37: 1-8.
• 37. Alper G, Narayanan V. Friedreich's ataxia. J Neurol 2009; 256(1): 3-8.
• 38. Gucev Z, Tasic V, Jancevska Aet al. Friedreich's ataxia (FA) associated with diabetes mellitus type 1 and hypertrophic cardiomyopathy: analysis of a FA family. Med Arh 2009; 63: 110-111.
• 39. Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol 2009; 1: 3-8.
• 40. Dürr A, Cossee M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 1996; 335: 1169-1175.
• 41. Harding AE. Friedreich’s ataxia: A clinical and genetic study of 90 families with an analysisof early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981; 104: 589- 620
• 42. Geoffrey G, Barbeau A, Breton G, et al. Clinical description and roentgenologic evaluation of patients with Friedreich’s ataxia. Can J Neurol Sci 1976; 3: 279-286. 43. Klockgether T, Chamberlain S, Wüllner U, et al. Late-onset Friedreich’s onance imaging. Arch Neurol 1993; 50:803-806.
• 44. Kostrzewa M, Klockgether T, Damian MS, et al. Locus heterogeneity in Friedreich ataxia. Neurogenetics 1997; 1: 43-47.
• 45. Harding A E. Early onset cerebellar ataxia with retained tendon reflexes: a clinical and genetic study of a disorder distinct from Friedreich's ataxia. J Neurol Neurosurg Psychiat 1981; 44: 503-508.
• 46. Klocgether T, lüdtke R, Kramer B, et al. The natural history of degenerative ataxia: A retrospective study in 446 patients. Brain 1998; 121: 589-600.
• 47. Tsou AY, Friedman LS, Wilson RB, Lynch DR. Pharmacotherapy for Friedreich ataxia. CNS Drugs 2009; 23: 213-23.
• 48. Artuch R, Aracil A, Mas A, et al. Friedreich’s ataxia: İdebenone treatment in early stage patients. Neuropediatrics 2002; 33: 190-193.
• 49. Di prospero N, Baker A, Jeffries N, et al. Neurological effects of high dose idebenone in patients with Friedreich’s ataxia: a randomized placebo controlled trial. Lancet Neurol 2007; 6: 878-886.
• 50. Brent L Fogel, Susan Perlman. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol 2007; 6: 245-257.
• 51. Gilfillan GD, Selmer KK, Roxrud I, et al. SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. Am J Hum Genet 2008; 82: 1003-1010.
• 52. Pondarre C, Campagna DR, Antiochos B, et al. The gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis. Blood 2007; 109: 3567- 3569.
• 53. Pagon RA, Bird TD, Detter JC. Hereditary sideroblastic anaemia and ataxia: an X linked recessive disorder. J Med Genet 1985; 22: 267-273.
• 54. Leehey MA, Berry-Kravis E, Min SJ, et al. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord 2007; 22: 203-206.
• 55. Jacquemont S, Farzin F, Hall D, et al. Aging in individuals with the FMR 1 mutation. Am J Ment Retard 2004; 109: 154-164.
• 56. Hagerman Rj, Coffey SM, et al. Neuropathy as a presenting feature in fragile X-associated tremor/ataxia syndrome. Am J Med Genet 2007; 143: 2256-60
• 57. Bacalman S, Farzin F, Bourgeois JA, et al. Psychiatric phenotype of the Fragile X-associated tremor/ataxia syndrome (FXTAS) in males; newly described Fronto-subcortical dementia. J Clin Psychiatry 2006; 67: 87-94
• 58. Cronister A, Schreiner R, Wittenberger M, et al. Heterozygous fagile X female: historical, physical, cognitive, and cytogenetic features. Am J Med Genet 1991; 38: 269-274.
• 59. Schöls L, Bauer P, Schmidt T, et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3: 291-304.
• 60. Banfi S, Servadio A, Chung M, et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nature Genet 1994; 7: 513-520.
• 61. Sasaki H, Fukazawa T, Yanagihara T, et al. Clinical features and natural history of spinocerebellar ataxia type 1. Acta Neurol Scand 1996; 93: 64-71.
• 62. Sriranjini SJ, Pal PK, Krishna N, Sathyaprabha TN. Subclinical pulmonary dysfunction in spinocerebellar ataxias 1, 2 and 3. Acta Neurol Scand DOI: 10.1111/j.1600- 404.2009.01306.x. (c) 2009.
• 63. Dang D, Cunnington D. Excessive daytime somnolence in spinocerebellar ataxia type, J Neurol Sci 2010; 290: 146-147.
• 64. Pulst, SM, Nechiporuk A, Nechiporuk T, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet 1996; 14: 269-276.
• 65. Ramos EM, Martins S, Alonso I, et al. Common origin of pure and interrupted repeat expansions in spinocerebellar ataxia type 2 (SCA2). Am J Med Genet B Neuropsychiatr Gene 2009; [Epub ahead of print]
• 66. Giunti P, Sabbadini G, Sweeney MG, et al. The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families: frequency, clinical and genetic correlates. Brain 1998; 121: 459-67.
• 67. Furtado S, Payami H, Lockhart PJ, et al. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 2004; 19: 622-9.
• 68. Modoni A, Contarino MF, Bentivoglio AR, et al. Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients. Mov Disord 2007; 22: 324-7.
• 69. Shan DE, Soong BW, Sum CM, et al. Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism. Ann Neurol 2001; 50: 812-15.
• 70. Özbek S, Güneş A, Zarifoğlu M, et al. Parkinsonizm Bulgularıyla Giden Spinoserebellar Ataksi Tip 2 Olgusu. Parkinson Hastalığı ve Hareket Bozuklukları Dergisi 2009; 12: 76-79.
• 71. Ağan K, Kutlu D, Başak N, et al. Spinocerebellar ataxia type 2 in a turkish family. Marmara Medical Journal 2006; 19: 135-8.
• 72. Schöls L, Haan J, Riess O et al. Sleep disturbance in spinocerebellar ataxias. is the SCA3 mutation a cause of restless legs syndrome? Neurology 1998; 51: 1603-07.
• 73. Flanigan K, Gardner K, Alderson K et al. Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1. Am J Hum Genet 1996; 59: 392-399.
• 74. Gardner K, Alderson K, Galster B, Kaplan C et al. Autosomal dominant spinocerebellar ataxia: clinical description of a distinct hereditary ataxia and genetic localization to chromosome 16 (SCA4) in a Utah kindred. Neurology 1994; 44: A361.
• 75. Hellenbroich Y, Bubel S, Pawlack H et al. Refinement of the spinocerebellar ataxia type 4 locus in a large German family and exclusion of CAG repeat expansions in this region. J Neurol 2003; 250: 668-671.
• 76. A. Stankewich, M. C. Tse, W. T. Peters, L. et al. A widely expressed beta-III spectrin associated with Golgi and cytoplasmic vesicles. Proc Nat Acad Sci 1998; 19: 14158-14163.
• 77. Shcöls L, Szymanski S, Peter S, et al. Genetic background of apparently idiopatic sporadic cerebellar ataxia. Hum Genet 2000; 107: 132-37.
• 78. Diriong S, Lory P, Williams ME, et al. Chromosomal localization of the human genes for alpha-1A, alpha-1B, and alpha-1E voltage-dependent Ca(2+) channel subunits. Genomics 1995; 30: 605-609.
• 79. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca(2+) channel gene CACNL1A4. Cell 1996; 87: 543-552.
• 80. David G., Abbas N., Stevanin G. et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genet 1997; 17: 65-70.
• 81. Michalik A., Del-Favero J., Mauger C. et al. Genomic organisation of the spinocerebellar ataxia type 7 (SCA7) gene responsible for autosomal dominant cerebellar ataxia with retinal degeneration. Hum Genet 1999; 105: 410-417.
• 82. Ikeda Y., Shizuka M., Watanabe M. et al. Molecular and clinical analyses of spinocerebellar ataxia type 8 in Japan. Neurology 2000; 54: 950-955.
• 83. Ito H., Kawakami H., Wate R. et al. Clinicopathologic investigation of a family with expanded SCA8 CTA/CTG repeats. Neurology 2006; 67: 1479-1481.
• 84. Koob MD, Moseley ML, Schut LJ, et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nature Genet 1999; 21: 379-384.
• 85. Higgins JJ, Pho LT, Ide SE, et al. Polymeropoulos, M. H. Evidence for a new spinocerebellar ataxia locus. Mov Disord 1997; 12: 412-417.
• 86. Matsuura T, Yamagata T, Burgess DL, et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nature Genet 2000; 26: 191-194.
• 87. Rasmussen A, Matsuura T, Ruano L, et al. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol 2001; 50: 234-239.
• 88. Houlden H, Johnson J, Gardner-Thorpe C, et al. Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11. Nature Genet 2007; 39: 1434-1436.
• 89. Holmes SE, O'Hearn EE, McInnis MG, et al. Expansion of a novel CAG trinucleotide repeat in the 5-prime region of PPP2R2B is associated with SCA12. Nature Genet 1999; 23: 391- 392.
• 90. Herman-Bert A, Stevanin G, Netter JC, et al. Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet 2000; 67: 229-235.
• 91. Waters MF, Minassian NA, Stevanin G, et al. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental nervous system phenotypes. Nature Genet 2006; 38: 447-451.
• 92. Brkanac Z, Bylenok L, Fernandez M, et al. A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. Arch Neurol 2002; 59: 1291-1295.
• 93. Chen DH, Brkanac Z, Verlinde C, et al. Missense mutations in the regulatory domain of PKCgamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet, 2003; 72: 839-849.
• 94. Storey E, Gardner RJM, Knight MA, et al. A new autosomal dominant pure cerebellar ataxia. Neurology 2001; 57: 1913-1915.
• 95. Iwaki A, Kawano Y, Miura S, et al. Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16. J Med Genet 2008; 45: 32-35.
• 96. Miura S, Shibata H, Furuya H, et al. The contactin 4 gene locus at 3p26 is a candidate gene of SCA16. Neurology 2006; 67: 1236-1241.
• 97. Koide R, Kobayashi S, Shimohata T, et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?. Hum. Molec Genet 1999; 8: 2047-2053.
• 98. Gao R, Matsuura T, Coolbaugh M, et al. Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17. Eur J Hum Genet 2008; 16: 215-22.
• 99. Minnerop M, Joe A, Lutz M, et al. Putamen dopamine transporter and glucose metabolism are reduced in SCA17. Ann Neurol 2005; 58: 490-491.
• 100. Brkanac Z, Fernandez M, Matsushita M, et al. Autosomal dominant sensory/motor neuropathy with ataxia (SMNA): linkage to chromosome 7q22-q32. Am J Med Genet 2002; 114: 450-457.
• 101. Brkanac Z, Spencer D, Shendure J, et al. IFRD1 is a candidate gene for SMNA on chromosome 7q22-q23. Am J Hum Genet 2009; 84: 692-697.
• 102. Schelhaas HJ, Ippel PF, Hageman G, et al. Clinical and genetic analysis of a fourgeneration fam ilywith a distinct autosomal dominant cerebellar ataxia. J Neurol 2001; 248: 113-120.
• 103. Verbeek DS, Schelhaas JH, Ippel EF, et al. Identification of a novel SCA locus (SCA19) in a Dutch autosomal dominant cerebellar ataxia family on chromosome region 1p21-q21. Hum Genet 2002; 111: 388-393.
• 104. Knight MA, Gardner RJM, Bahlo M, et al. Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20. Brain 2004; 127: 1172-1181.
• 105. Coutinho P, Cruz VT, Tuna A, et al. Cerebellar ataxia with spasmodic cough: a new form of dominant ataxia. Arch Neurol 2006; 63: 553-555.
• 106. Devos D, Schraen-Maschke S, Vuillaume I, et al. Clinical features and genetic analysis of a new form of spinocerebellar ataxia. Neurology 2001; 56: 234-238.
• 107. Vuillaume I, Devos D, Schraen-Maschke S, et al. A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1. Ann Neurol 2002; 52: 666-670.
• 108. Schelhaas HJ, Ippel PF, Hageman G, et al. Clinical and genetic analysis of a fourgeneration family with a distinct autosomal dominant cerebellar ataxia. J Neurol 2001; 248:113-120.
• 109. Chung M, Lu YC, Cheng NC, et al. A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. Brain 2003; 126: 1293-1299.
• 110. Verbeek DS, van de Warrenburg BP, Wesseling P, et al. Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3. Brain 2004; 127: 2551-2557.
• 111. Stevanin G, Bouslam N, Thobois S, et al. Spinocerebellar ataxia with sensory neuropathy (SCA25) maps to chromosome 2p. Ann Neurol 2004; 55: 97-104.
• 112. Yu GY, Howell MJ, Roller MJ, et al. Spinocerebellar ataxia type 26 maps to chromosome 19p13.3 adjacent to SCA6. Ann Neurol 2005; 57: 349-354.
• 113. Van Swieten JC, Brusse E, de Graaf BM, et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebral (sic) ataxia. Am J Hum Genet 2003; 72: 191-199.
• 114. Dalski A, Atici J, Kreuz FR, et al. Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxias. Europ J Hum Genet, 2005; 13: 118-120.
• 115. Cagnoli C, Mariotti C, Taroni F, et al. SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2. Brain 2006; 129: 235-242.
• 116. Storey E, Bahlo M, Fahey M, et al. A new dominantly inherited pure cerebellar ataxia, SCA 30. J Neurol Neurosurg Psychiatry 2009; 80: 408-411.
• 117. Onodera O, Oyake M, Takano H, et al. Molecular cloning of a full-length cDNA for dentatorubral-pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS. Am J Hum Genet 1995; 57: 1050-1060.
• 118. Naito H, Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. Neurology 1982; 32: 798-807.
• 119. Farmer TW, Wingfield MS, Lynch SA, et al. Ataxia, chorea, seizures, and dementia: pathologic features of a newly defined familial disorder. Arch Neurol 1989; 46:774-779.
• 120. Wardle M, Morris HR, Robertson NP. Clinical and genetic characteristics of non-Asian dentatorubral-pallidoluysian atrophy: A systematic review. Mov Disord 2009; 24: 1636-640.
• 121. Öner C. Genetik kavramlar. 6. baskı. Ankara: Palme Yayıncılık, 2002; 744-746.
• 122. İşcan M. Moleküler genetikte modern teknikler. Biyoinformatik-2003 (Teori ve Uygulama) Lisansüstü Yaz Okulu Erzurum-Türkiye, 22-28 Haziran 2003; 71-77
• 123. Kalaycıoğlu A, Öner C, Birben E, Bozkurt A. PCR tekniği ve DNA parmakizi analizi. Uygulamalı Moleküler Biyoloji Teknikleri Lisansüstü Yaz Okulu Ankara-Türkiye, 7-13 Eylül 1997; 29-34.
• 124. Sambrook J, Fritsch EF, ManiatisT. Molecular cloning, A laboratory manual. 2nd Ed., Cold spring harbor laboratory pres 1989. 125. Cooper GM. The cell a molecular approach. ASM Press Washington DC, 1997; 113.
• 126. Watson JD, Gilman M, Witkowski J, Zollar M. Recombinant DNA. 2nd Ed., Scientific American books US 1992; 79-82.
• 127. Bozkurt G, Algüneş Ç. Tıpta moleküler genetik uygulamaları genel prensipleri. Edirne: Trakya Üniversitesi Matbaa Tesisleri 2000; 42-46, 66-69.
• 128. Solak M, Bağcı H, Şengil AZ, Öztaş S. Moleküler genetik ve rekombinant DNA teknolojisi. Afyon: Uyun Ajans 2000; 130-133, 135.
• 129. Kocatürk Sel S. Spinal müsküler atrofi hastalarında SMN geni ekzon 7 ve 8'in moleküler analizi. Yüksek Lisans Tezi 2005.
• 130. http://www.genetiklab.com Kapiller elektroforez sistemlerinde relatif flouresan kantitasyon 13.02.2010.
• 131. Özer N, Öğüş H. Elektroforez ve izoelektrik odaklama. Biyokimyada temel ve modern teknikler Biyokimya Lisansüstü Yaz Okulu Kuşadası-Türkiye, 27 Ağustos-3 Eylül 2000; 251- 260.
• 132. Özer N, Öğüş H. Kapiller Elektroforez. In: Telefoncu A, Zihnioğlu F, Kılınç A, Salnıkow J. Biyokimyada Temel ve Modern Teknikler Bornova: Ege Üniversitesi, 2000; 279-294.
• 133. Aşıcıoğlu F, Koluaçık S, Çetinkaya Ü, Akyüz F, Kapiller Elektroforez Teknolojisinin Klinik ve Adli Amaçlı DNA Analizlerinde Kullanımı: Geleneksel jel elektroforez yöntemi ile karşılaştırma. Adli Tıp Derg 2002; 16: 88-93.
• 134. Dilsiz N. Moleküler biyoloji. Palme Yayıncılık, Ankara. 2004.
• 135. İzbırak A, Güler G, Tan S. DNA’nın agaroz jel elektroforezi ve spektrofotometrik miktar tayini. Uygulamalı Moleküler Biyoloji Teknikleri Lisansüstü Yaz Okulu Ankara-Türkiye, 7-13 Eylül 1997; 17-25.
• 136. http://www.drzeydanli.com.tr/images/image/Elektroforez%20.JPG.